eamdacademy.org-1VRd-1790276617-l425336326 1790276617 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2026 5 2 Fatima Zahra Amrani Youssef Benali 2026 10.68159/l425336326 https://eamdacademy.org/pub/journal/3/article/l425336326 Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and the United States. Chinese Med J. 2022;135(05):584-90. Hanahan D. Hallmarks of cancer: new dimensions. Cancer Dis. 2022;12(1):31-46. Little M, Jordens F, Paul K, Montgomery K, Philipson B. Liminality: a major category of the experience of cancer illness. J Bioet Inq. 2022:19(1):37-48. Brenner DR, Weir HK, Demers AA, Ellison LF, Louzado C, Shaw A, et al. Projected estimates of cancer in Canada in 2020. Canada Med Assoc. 2020;192(9):199-205. Hong S, Won Y, Park Y, Jung K, Kong H, Lee E. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer research and treatment. J Korean Cancer Assoc. 2020;52(2):335-50. Mathur P, Sathishkumar K, Chaturvedi M, Das P, Sudarshan L, Santhappa S, et al. Cancer statistics, 2020: report from national cancer registry programme, India. JCO Global Oncol. 2020;6:106375. Pucot JR, Manting MM, Demayo CG. Ethnobotanical plants used by selected indigenous peoples of Mindanao, the Philippines as cancer therapeutics. Pharmacophore. 2019;10(3):61-9. Babaei H, Sepahy AA, Amini K, Saadatmand S. The effect of titanium dioxide nanoparticles synthesized by Bacillus tequilensis on clb gene expression of colorectal cancer-causing Escherichia coli. Arch Pharm Pract. 2020;11(1):22-31. Alhomayani FK, Althumali AM, Alhamyani A, Alsufyani AA, Alharthi NA, Almalki MS. Awareness of hemodialysis patients regarding symptoms of cancer at King Abdul-Aziz specialized hospital, Taif city. Arch Pharm Pract. 2020;11(2):69-80. Uhlenhopp D, Then E, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology, and risk factors. Clin J Gast. 2020;13(6):1010-21. Zhang S, Xu H, Zhang L, Qiao Y. Cervical cancer: epidemiology, risk factors, and screening. Chinese J Cancer Res. 2020;32(6):720. Sun D, Li H, Cao M, He S, Lei L, Peng J, et al. Cancer burden in China: trends, risk factors, and prevention. Cancer Biol Med. 2020;17(4):879. Georgakopoulos-Soares I, Chartoumpekis D, Kyriazopoulou V, Zaravinos A. EMT factors and metabolic pathways in cancer. Frontiers Oncol. 2020;10:499. Saha G, Sarkar S, Mohanta P, Kumar K, Chakrabarti S, Basu M, et al. USP7 targets XIAP for cancer progression: establishment of a p53-independent therapeutic avenue for glioma. Oncogene. 2022;41(47):5061-75. Daoud M, Broxtermann P, Schorn F, Werthenbach J, Seeger J, Schiffmann L, et al. XIAP promotes melanoma growth by inducing tumour neutrophil infiltration. EMBO Rep. 2022;23(6):e53608. Hanifeh M, Ataei F. XIAP as a multifaceted molecule in Cellular Signaling. Apoptosis. 2022;27(7-8):441-53. Kuo YC, Yang I, Rajesh R. Suppressed XIAP and cIAP expressions in human brain cancer stem cells using BV6-and GDC0152-encapsulated nanoparticles. J Taiwan Inst Chem Eng. 2022;135:104394. Cremona M, Vandenberg CJ, Farrelly AM, Madden SF, Morgan C, Kalachand R, et al. BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors. Br J Cancer. 2022;127(3):488-99. Li J, Cen W, Tong C, Wang L, Zhang W, Deng S, et al. Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis. Plos One. 2022;17(4):e0266738. Yin S, Chen Y, Tong H, Li T, Qin Z, Zhu J, et al. PP2A promotes apoptosis and facilitates docetaxel sensitivity via the PP2A/p eIF4B/XIAP signaling pathway in prostate cancer. Oncol Lett. 2022;23(3):1-9. Wilke N, Abodo L, Frias C, Frias J, Baas J, Jakupec M, et al. The gallium complex KP46 sensitizes resistant leukemia cells and overcomes Bcl-2-induced multidrug resistance in lymphoma cells via upregulation of Harakiri and downregulation of XIAP in vitro. Biom Pharmacother. 2022;156:113974. Xu M, Zhang L, Guo Y, Bai L, Luo Y, Wang B, et al. Nanoemulsion Co-Loaded with XIAP siRNA and gambogic acid for inhalation therapy of lung cancer. Int J Mol Sci. 2022;23(22):14294. Engelmann C, Schuhmachers P, Zdimerova H, Virdi S, Hauri-Hohl M, Pachlopnik- Schmid J, et al. Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1. Cell Death Dis. 2022;13(10):892. Cater M, Haupt Y. Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. Biochem J. 2011;436(2):481-91. Sun, H, Lu J, Liu L, Yi H, Qiu S, Yang C, et al. Nonpeptidic and potent small-molecule inhibitors of cIAP-1/2 and XIAP proteins. J Med Chem. 2010;53(17):6361-7. Kester R, Donnell A, Lou Y, Remiszewski S, Lombardo L, Chen S, et al. Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain. J Med Chem. 2013;56(20):7788-03. Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller P, et al. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem. 2004;47(10):2430-40. Peng Y, Sun H, Lu J, Liu L, Cai Q, Shen R, et al. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents. J Med Chem. 2012;55(1):106-14. National Library of Medicine. National Center for Biotechnology Information. available from: https://pubchem.ncbi.nlm.nih.gov Wu Z, Gu L, Zhang S, Liu T, Lukka PB, Meibohm B, et al. Discovery of N-(3, 4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2, 3, 3a, 4, 5, 9b-hexahydrofuro [3, 2-c] quinoline-8-sulfonamide as a Potent Dual MDM2/XIAP Inhibitor. J Med Chem. 2021;64(4):1930-50. Danquah M, Duke C, Patil R, Miller D, Mahato R. Combination therapy of antiandrogen and XIAP inhibitor for treating advanced prostate cancer. Pharm Res. 2012;29:2079-91. Polykretis P, Luchinat E, Bonucci A, Giachetti A, Graewert M, Svergun D, et al. Conformational characterization of full-length X-chromosome-linked inhibitor of apoptosis protein (XIAP) through an integrated approach. IUCrJ. 2019;6(5):948-57. Figueroa-Valverde L, Rosas-Nexticapa M, Montserrat M, Díaz-Cedillo F, López-Ramos M, Alvarez-Ramirez M, et al. Synthesis and Theoretical Interaction of 3-(2-oxabicyclo [7.4. 0] trideca-1 (13), 9, 11-trien-7-yn-12-yloxy)-steroid Derivative with 17β-hydroxysteroid Dehydrogenase Enzyme Surface. Bioint Res Appl Chem. 2023;13:266. Lauro F, Marcela R, Maria L, Francisco D, Magdalena A, Virginia M, et al. Effect produced by a cyclooctyne derivative on both infarct area and left ventricular pressure via calcium channel activation. Drug Res. 2023. 10.1055/a-1967-2004 Rudik A, Dmitriev A, Lagunin A, Filimonov D, Poroikov V. Computational prediction of inhibitors and inducers of the major isoforms of cytochrome P450. Molecules. 2022;27(18):1-9. Schön K, Koristkova B, Kacirova I, Brozmanova H, Grundmann M. Comparison of Mw\Pharm 3.30 and Mw\Pharm++, a Windows version of pharmacokinetic software for PK/PD monitoring of vancomycin. Part 1: A-posteriori modelling. Comp Met Prog Biom. 2022;214:106552. Grassin-Delyle S, Semeraro M, Lamy E, Urien S, Runge I, Foissac F, et al. Pharmacokinetics of tranexamic acid after intravenous, intramuscular, and oral routes: a prospective, randomised, crossover trial in healthy volunteers. British J Anaest. 2022;128(3):465-72. Wechalekar A, Sanchorawala V. Daratumumab in AL amyloidosis. Blood J Am Soc Hematol. 2022;140(22):2317-22. Lauro F, Marcela R, Maria LR, Magdalena A, Virginia M, Francisco D, et al. Evaluation of biological activity of a diazocine derivative against heart failure using an ischemia-reperfusion injury model. Drug Res. 2022;72(07):404-11. Zhu Q, Yang Y, Lao Z, Zhong Y, Zhang K, Zhao S. Acute and chronic toxicity of deltamethrin, permethrin, and dihaloacetylated heterocyclic pyrethroids in mice. Pest Manag Sci. 2020;76(12):4210-21. Zhu Q, Yang Y, Lao Z, Zhong Y, Zhang K, Zhao S. Photodegradation kinetics, mechanism and aquatic toxicity of deltamethrin, permethrin and dihaloacetylated heterocyclic pyrethroids. Sci Environ. 2020;749:142106. Kisielius V, Hama J, Skrbic N, Hansen H, Strobel B, Rasmussen L. The invasive butterbur contaminates stream and seepage water in groundwater wells with toxic pyrrolizidine alkaloids. Scic Rep. 2020;10(1):1-10. Alimoradi S, Stohr H, Stagg-Williams S, Sturm B. Effect of temperature on toxicity and biodegradability of dissolved organic nitrogen formed during hydrothermal liquefaction of biomass. Chemos. 2020;238:124573.